(Q33908682)

29 July 2017

1 reference

https://doi.org/10.1002/14651858.CD000299.pub2

1 reference

29 December 2023

http://retractionwatch.com/2010/09/20/progressive-how-the-cochrane-library-handles-updates-in-progress/

title

Anti-tuberculous therapy for maintaining remission of Crohn's disease (English)

1 reference

29 July 2017

0 references

M Borgaonkar

1

1 reference

29 July 2017

D MacIntosh

series ordinal

2

1 reference

29 July 2017

J Fardy

series ordinal

3

1 reference

29 July 2017

L Simms

series ordinal

4

1 reference

29 July 2017

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

1 reference

29 July 2017

CD000299

1 reference

29 July 2017

2

1 reference

Controlled trial of rifampicin and ethambutol in Crohn's disease

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000299

Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000299

Mycobacteria as a possible cause of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000299

Johne's and Crohn's. Chronic inflammatory bowel diseases of infectious aetiology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000299

Controlled trial of antimycobacterial therapy in Crohn's disease. Clofazimine versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000299

Sulphadoxine-pyrimethamine therapy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000299

10.1002/14651858.CD000299

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference